Cargando…

Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation

BACKGROUND: The optimal marker for cyclosporine (CsA) monitoring in transplantation patients remains controversial. However, there is a growing interest in the use of the area under the concentration-time curve (AUC), particularly for cyclosporine dose adjustment in pediatric hematopoietic stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarem, Sarem, Li, Jun, Barriere, Olivier, Litalien, Catherine, Théorêt, Yves, Lapeyraque, Anne-Laure, Nekka, Fahima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237955/
https://www.ncbi.nlm.nih.gov/pubmed/25192585
http://dx.doi.org/10.1186/1742-4682-11-39
_version_ 1782345433889112064
author Sarem, Sarem
Li, Jun
Barriere, Olivier
Litalien, Catherine
Théorêt, Yves
Lapeyraque, Anne-Laure
Nekka, Fahima
author_facet Sarem, Sarem
Li, Jun
Barriere, Olivier
Litalien, Catherine
Théorêt, Yves
Lapeyraque, Anne-Laure
Nekka, Fahima
author_sort Sarem, Sarem
collection PubMed
description BACKGROUND: The optimal marker for cyclosporine (CsA) monitoring in transplantation patients remains controversial. However, there is a growing interest in the use of the area under the concentration-time curve (AUC), particularly for cyclosporine dose adjustment in pediatric hematopoietic stem cell transplantation. In this paper, we develop Bayesian limited sampling strategies (B-LSS) for cyclosporine AUC estimation using population pharmacokinetic (Pop-PK) models and investigate related issues, with the aim to improve B-LSS prediction performance. METHODS: Twenty five pediatric hematopoietic stem cell transplantation patients receiving intravenous and oral cyclosporine were investigated. Pop-PK analyses were carried out and the predictive performance of B-LSS was evaluated using the final Pop-PK model and several related ones. The performance of B-LSS when targeting different versions of AUC was also discussed. RESULTS: A two-compartment structure model with a lag time and a combined additive and proportional error is retained. The final covariate model does not improve the B-LSS prediction performance. The best performing models for intravenous and oral cyclosporine are the structure ones with combined and additive error, respectively. Twelve B-LSS, consisting of 4 or less sampling points obtained within 4 hours post-dose, predict AUC with 95(th) percentile of the absolute values of relative prediction errors of 20% or less. Moreover, B-LSS perform better for the prediction of the ‘underlying’ AUC derived from the Pop-PK model estimated concentrations that exclude the residual errors, in comparison to their prediction of the observed AUC directly calculated using measured concentrations. CONCLUSIONS: B-LSS can adequately estimate cyclosporine AUC. However, B-LSS performance is not perfectly in line with the standard Pop-PK model selection criteria; hence the final model might not be ideal for AUC prediction purpose. Therefore, for B-LSS application, Pop-PK model diagnostic criteria should additionally account for AUC prediction errors.
format Online
Article
Text
id pubmed-4237955
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42379552014-11-21 Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation Sarem, Sarem Li, Jun Barriere, Olivier Litalien, Catherine Théorêt, Yves Lapeyraque, Anne-Laure Nekka, Fahima Theor Biol Med Model Research BACKGROUND: The optimal marker for cyclosporine (CsA) monitoring in transplantation patients remains controversial. However, there is a growing interest in the use of the area under the concentration-time curve (AUC), particularly for cyclosporine dose adjustment in pediatric hematopoietic stem cell transplantation. In this paper, we develop Bayesian limited sampling strategies (B-LSS) for cyclosporine AUC estimation using population pharmacokinetic (Pop-PK) models and investigate related issues, with the aim to improve B-LSS prediction performance. METHODS: Twenty five pediatric hematopoietic stem cell transplantation patients receiving intravenous and oral cyclosporine were investigated. Pop-PK analyses were carried out and the predictive performance of B-LSS was evaluated using the final Pop-PK model and several related ones. The performance of B-LSS when targeting different versions of AUC was also discussed. RESULTS: A two-compartment structure model with a lag time and a combined additive and proportional error is retained. The final covariate model does not improve the B-LSS prediction performance. The best performing models for intravenous and oral cyclosporine are the structure ones with combined and additive error, respectively. Twelve B-LSS, consisting of 4 or less sampling points obtained within 4 hours post-dose, predict AUC with 95(th) percentile of the absolute values of relative prediction errors of 20% or less. Moreover, B-LSS perform better for the prediction of the ‘underlying’ AUC derived from the Pop-PK model estimated concentrations that exclude the residual errors, in comparison to their prediction of the observed AUC directly calculated using measured concentrations. CONCLUSIONS: B-LSS can adequately estimate cyclosporine AUC. However, B-LSS performance is not perfectly in line with the standard Pop-PK model selection criteria; hence the final model might not be ideal for AUC prediction purpose. Therefore, for B-LSS application, Pop-PK model diagnostic criteria should additionally account for AUC prediction errors. BioMed Central 2014-09-05 /pmc/articles/PMC4237955/ /pubmed/25192585 http://dx.doi.org/10.1186/1742-4682-11-39 Text en Copyright © 2014 Sarem et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sarem, Sarem
Li, Jun
Barriere, Olivier
Litalien, Catherine
Théorêt, Yves
Lapeyraque, Anne-Laure
Nekka, Fahima
Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
title Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
title_full Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
title_fullStr Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
title_full_unstemmed Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
title_short Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
title_sort bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237955/
https://www.ncbi.nlm.nih.gov/pubmed/25192585
http://dx.doi.org/10.1186/1742-4682-11-39
work_keys_str_mv AT saremsarem bayesianapproachfortheestimationofcyclosporineareaunderthecurveusinglimitedsamplingstrategiesinpediatrichematopoieticstemcelltransplantation
AT lijun bayesianapproachfortheestimationofcyclosporineareaunderthecurveusinglimitedsamplingstrategiesinpediatrichematopoieticstemcelltransplantation
AT barriereolivier bayesianapproachfortheestimationofcyclosporineareaunderthecurveusinglimitedsamplingstrategiesinpediatrichematopoieticstemcelltransplantation
AT litaliencatherine bayesianapproachfortheestimationofcyclosporineareaunderthecurveusinglimitedsamplingstrategiesinpediatrichematopoieticstemcelltransplantation
AT theoretyves bayesianapproachfortheestimationofcyclosporineareaunderthecurveusinglimitedsamplingstrategiesinpediatrichematopoieticstemcelltransplantation
AT lapeyraqueannelaure bayesianapproachfortheestimationofcyclosporineareaunderthecurveusinglimitedsamplingstrategiesinpediatrichematopoieticstemcelltransplantation
AT nekkafahima bayesianapproachfortheestimationofcyclosporineareaunderthecurveusinglimitedsamplingstrategiesinpediatrichematopoieticstemcelltransplantation